Back to top
more

Sanofi (SNY)

(Delayed Data from NYSE)

 Add to portfolio

Trades from $3

$45.90 USD

45.90
3,973,977

+1.81 (4.11%)

Updated Apr 24, 2017 04:02 PM ET

Volume: 3,973,977

Open: $46.11

Prior Close: $44.09

2-Buy   2      

Value: A | Growth: B | Momentum: A | VGM: A

The Zacks Scorecard is a complimentary set of indicators to use alongside the Zacks Rank. It allows the investor to better focus on the stocks that are the best fit for his or her personal investment style.

We produce five unique ratings, including the Zacks Style Score, which combines the individual style scores into 1 rating:

Zacks Style Score A
Growth Score A
Value Score A
Momentum Score A
Income Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a score of an A or a B in your personal trading style.

Zacks Scorecard Education - Learn more about the Zacks Scorecard

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 25.71%
2 Buy 18.12%
3 Hold 9.91%
4 Sell 5.49%
5 Strong Sell 2.29%
S&P 500 9.79%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

Balance Sheet

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

Research for SNY

   

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

Fiscal Year End for Sanofi falls in the month of December.

All items in Millions except Per Share data.

12/31/2016 12/31/2015 12/31/2014 12/31/2013 12/31/2012
Assets          
Cash & Equivalents 11,368 10,281 10,048 11,214 8,436
Receivables 8,090 8,201 9,503 9,074 9,655
Notes Receivable 0 0 0 0 0
Inventories 7,627 7,235 8,723 8,437 8,204
Other Current Assets 2,447 1,962 2,867 3,038 3,029
Total Current Assets 29,532 27,680 31,142 31,762 29,323
Net Property & Equipment 11,087 11,041 13,819 13,525 13,604
Investments & Advances 3,198 2,971 6,592 7,005 5,512
Other Non-Current Assets 7,105 6,387 13 19 130
Deferred Charges 5,167 5,234 6,460 5,518 5,629
Intangibles 56,620 57,278 71,437 69,774 74,935
Deposits & Other Assets 3,121 3,026 0 0 0
Total Assets 115,830 113,617 129,463 127,603 129,133
Liabilities & Shareholders Equity 12/31/2016 12/31/2015 12/31/2014 12/31/2013 12/31/2012
Notes Payable 0 0 0 0 0
Accounts Payable 4,755 4,238 4,853 3,989 4,103
Current Portion Long-Term Debt 1,952 3,815 2,044 5,547 4,903
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 11,479 10,629 10,426 9,003 8,820
Total Current Liabilities 18,186 18,682 17,323 18,539 17,825
Mortgages 0 0 0 0 0
Deferred Taxes/Income 2,536 3,215 5,457 6,721 7,629
Convertible Debt 0 0 0 0 0
Long-Term Debt 18,607 14,566 17,648 13,833 13,786
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 12,623 12,518 14,238 12,778 15,979
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 51,953 48,981 54,666 51,871 55,219
Shareholders Equity 12/31/2016 12/31/2015 12/31/2014 12/31/2013 12/31/2012
Preferred Stock 0 0 0 0 0
Common Stock (Par) 2,859 2,899 3,508 3,519 3,412
Capital Surplus 56,964 57,752 69,859 70,470 68,039
Retained Earnings 0 0 0 0 0
Other Equity 5,717 4,316 2,353 2,067 2,730
Treasury Stock 1,663 331 923 324 266
Total Shareholder's Equity 63,877 64,636 74,797 75,732 73,915
Total Liabilities & Shareholder's Equity 115,830 113,617 129,463 127,603 129,133
Total Common Equity 63,877 64,636 74,797 75,732 73,915
Shares Outstanding 2,543.80 2,611.30 2,638.70 2,648.60 2,648.60
Book Value Per Share 25.11 24.75 28.35 28.59 27.91

Fiscal Year End for Sanofi falls in the month of December.

All items in Millions except Per Share data.

3/31/2017 12/31/2016 9/30/2016 6/30/2016 3/31/2016
Assets          
Cash & Equivalents NA 11,368 0 7,010 0
Receivables NA 8,090 0 8,235 0
Notes Receivable NA 0 0 0 0
Inventories NA 7,627 0 7,983 0
Other Current Assets NA 2,447 0 2,002 0
Total Current Assets NA 29,532 0 25,230 0
Net Property & Equipment NA 11,087 0 11,092 0
Investments & Advances NA 3,198 0 3,080 0
Other Non-Current Assets NA 7,105 0 6,789 0
Deferred Charges NA 5,167 0 6,091 0
Intangibles NA 56,620 0 57,061 0
Deposits & Other Assets NA 3,121 0 2,616 0
Total Assets NA 115,830 0 111,958 0
Liabilities & Shareholders Equity 3/31/2017 12/31/2016 9/30/2016 6/30/2016 3/31/2016
Notes Payable NA 0 0 0 0
Accounts Payable NA 4,755 0 4,437 0
Current Portion Long-Term Debt NA 1,952 0 2,742 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 0 0 0 0
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 11,479 0 10,041 0
Total Current Liabilities NA 18,186 0 17,220 0
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 2,536 0 3,134 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 18,607 0 16,775 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 0 13,440 0
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 51,953 0 50,568 0
Shareholders Equity 3/31/2017 12/31/2016 9/30/2016 6/30/2016 3/31/2016
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 2,859 0 2,908 0
Capital Surplus NA 56,964 0 54,399 0
Retained Earnings NA 0 0 0 0
Other Equity NA 5,717 0 4,084 0
Treasury Stock NA 1,663 0 0 0
Total Shareholder's Equity NA 63,877 0 61,390 0
Total Liabilities & Shareholder's Equity NA 115,830 0 111,958 0
Total Common Equity 0 63,877 0 61,390 0
Shares Outstanding 2,543.80 2,543.80 2,574.20 2,574.20 2,573.40
Book Value Per Share 0.00 25.11 0.00 23.85 0.00